MedTrace Logo

Conventional Versus Hypofractionated Radiotherapy in Node Positive Breast Cancer

NCT02690636 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2016-06-01

No results posted yet for this study

Summary

Breast cancer patients operated with modified radical mastectomy or breast conservative surgery will be randomized for either adjuvant conventional radiotherapy versus hypofractionated radiotherapy for chest wall and axilla or breast and axilla.

The patients will be recruited for one year and will be followed for 5 years by monitoring local recurrence, cosmetic outcomes, health economic perspectives, and arm lymph edema.

Conditions

Interventions

RADIATION

radiotherapy

daily fractions, five fractions per week.

Sponsors & Collaborators

  • Mit Ghamr Oncology Center

    collaborator OTHER

  • Clinical Oncology department. Elmansoura University.

    collaborator UNKNOWN

  • Zagazig University

    collaborator OTHER_GOV

  • Assiut University

    collaborator OTHER

  • Tanta University

    collaborator OTHER

  • Al-Azhar University

    collaborator OTHER

  • Medical Research Institute. Department of Cancer Management and Research.

    collaborator UNKNOWN

  • Cairo University

    collaborator OTHER

  • Clinical Oncology Department. Banha University.

    collaborator UNKNOWN

  • Ayadi El Mostakbal Cancer Center. Alexandria.

    collaborator UNKNOWN

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Mahmoud Ellithy, Phd · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2021-02-28
Completion
2021-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02690636 on ClinicalTrials.gov